DK164175A - Thienyl- og thietylurinstofderivater samt deres fremstilling og anvendelse - Google Patents

Thienyl- og thietylurinstofderivater samt deres fremstilling og anvendelse

Info

Publication number
DK164175A
DK164175A DK164175A DK164175A DK164175A DK 164175 A DK164175 A DK 164175A DK 164175 A DK164175 A DK 164175A DK 164175 A DK164175 A DK 164175A DK 164175 A DK164175 A DK 164175A
Authority
DK
Denmark
Prior art keywords
thietylurin
thienyl
manufacture
substance derivatives
derivatives
Prior art date
Application number
DK164175A
Other languages
Danish (da)
English (en)
Inventor
P E Aldrich
G H Berezin
B I Dittmar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK164175A publication Critical patent/DK164175A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D331/00Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK164175A 1974-04-17 1975-04-16 Thienyl- og thietylurinstofderivater samt deres fremstilling og anvendelse DK164175A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
DK164175A true DK164175A (da) 1975-10-18

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
DK164175A DK164175A (da) 1974-04-17 1975-04-16 Thienyl- og thietylurinstofderivater samt deres fremstilling og anvendelse

Country Status (21)

Country Link
US (1) US4009847A (xx)
JP (1) JPS50148349A (xx)
AR (1) AR208545A1 (xx)
CA (1) CA1047042A (xx)
CH (1) CH611292A5 (xx)
DD (1) DD117223A5 (xx)
DE (1) DE2516554A1 (xx)
DK (1) DK164175A (xx)
ES (1) ES436648A1 (xx)
FI (1) FI751128A (xx)
FR (1) FR2267773B1 (xx)
GB (1) GB1461209A (xx)
HU (1) HU173052B (xx)
IE (1) IE41143B1 (xx)
IL (1) IL47095A (xx)
LU (1) LU72306A1 (xx)
NL (1) NL7504570A (xx)
NO (1) NO144071C (xx)
PH (1) PH11722A (xx)
SE (1) SE417965B (xx)
YU (1) YU96075A (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
RU2319693C9 (ru) 1999-01-13 2008-08-20 Байер Копэрейшн Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
EP1158985B1 (en) * 1999-01-13 2011-12-28 Bayer HealthCare LLC OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
EP1769795B1 (en) * 2001-12-03 2013-07-24 Bayer HealthCare LLC Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
EP1478358B1 (en) * 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
WO2003068223A1 (en) * 2002-02-11 2003-08-21 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
WO2003068229A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
AU2003209118A1 (en) * 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
UY28213A1 (es) * 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
CA2526636C (en) * 2003-05-20 2012-10-02 Bayer Pharmaceuticals Corporation Diaryl ureas for diseases mediated by pdgfr
CL2004001834A1 (es) * 2003-07-23 2005-06-03 Bayer Pharmaceuticals Corp Compuesto 4-{4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenoxi}-piridin-2-metilamida, inhibidor de la raf, vegfr, p38 y pdgfr quinasas, sus sales; composiicon farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperprol
MXPA06012394A (es) * 2004-04-30 2007-01-31 Bayer Pharmaceuticals Corp Derivados de pirazolilurea sustituidos utiles en el tratamiento de cancer.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
NL7504570A (nl) 1975-10-21
CA1047042A (en) 1979-01-23
LU72306A1 (xx) 1976-03-17
IL47095A0 (en) 1975-06-25
JPS50148349A (xx) 1975-11-27
HU173052B (hu) 1979-02-28
FR2267773A1 (xx) 1975-11-14
YU96075A (en) 1983-04-27
GB1461209A (en) 1977-01-13
FR2267773B1 (xx) 1978-08-18
DE2516554A1 (de) 1975-10-30
DD117223A5 (xx) 1976-01-05
IE41143L (en) 1975-10-17
FI751128A (xx) 1975-10-18
US4009847A (en) 1977-03-01
IE41143B1 (en) 1979-10-24
AR208545A1 (es) 1977-02-15
NO751351L (xx) 1975-10-20
CH611292A5 (xx) 1979-05-31
NO144071B (no) 1981-03-09
PH11722A (en) 1978-05-30
SE417965B (sv) 1981-04-27
IL47095A (en) 1978-03-10
NO144071C (no) 1981-06-17
ES436648A1 (es) 1977-08-01
AU8013575A (en) 1976-10-21
SE7503523L (sv) 1975-10-20

Similar Documents

Publication Publication Date Title
DK164175A (da) Thienyl- og thietylurinstofderivater samt deres fremstilling og anvendelse
DK248376A (da) Isoxazolderivater samt deres fremstilling og anvendelse
DK310575A (da) 4-trifluormethyl-phenoxy-phenoxypropionsyreforbindelser samt deres fremstilling og anvendelse
DK211775A (da) Substituerede phenylguanidiner samt deres fremstilling og anvendelse
DK571476A (da) Indolderivater deres fremstilling og anvendelse
DK56876A (da) Prostaglandinanaloge samt deres fremstilling og anvendelse
DK571376A (da) Indolderivater deres fremstilling og anvendelse
DK287476A (da) Pyrrolidoner samt deres fremstilling og anvendelse
DK581075A (da) Prostaglandinanaloge samt deres fremstilling og anvendelse
DK353575A (da) 1-thiadiazolylimidazolidinoner samt deres fremstilling og anvendelse
DK286676A (da) Bicycloheptenforbindelser samt deres fremstilling og anvendelse
DK340475A (da) Thiazolidinderivater samt deres fremstilling og anvendelse
DK496775A (da) Prostaglandinpyrrolidoner samt deres fremstilling og anvendelse
DK449575A (da) Urinstofderivater samt deres fremstilling og anvendelse som fungicider
DK321775A (da) Substituerede phenylisothiourinstoffer samt deres fremstilling og anvendelse
DK191375A (da) Isoflavonderivater, deres fremstilling og anvendelse
DK179975A (da) Benzoinethere samt deres fremstilling og anvendelse
DK457275A (da) Derivater af fragmentet b af difteritoxinet samt deres fremstilling og anvendelse
NL7504171A (nl) Tetracyclinederivaten en hun bereiding.
DK548175A (da) Cyclopropancarboxylsyreestere samt deres fremstilling og anvendelse
DK554776A (da) Prostaglandinanaloge pyrrolidoner samt deres fremstilling og anvendelse
DK590075A (da) Thiourinstofderivater samt deres fremstilling og anvendelse som fugicider
DK281476A (da) Pyrrolidoner samt deres fremstilling og anvendelse
DK246375A (da) Cyclopentanderivater samt deres fremstilling og anvendelse
DK426376A (da) 4-hydroxymethyl-2-pyrrolidinoner samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn
PBP Patent lapsed